Kenji M Fujihara

9PUBLICATIONS
60CO-AUTHORS
Molecular targetsHealth and ecological risk assessmentLiquid biopsiesElectrical energy transmission, networks and systemsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 21, 2026
Targeting DNA Polymerase Epsilon Induces Tumor Clearance and Activates an NF-κB-Mediated Inflammatory Response in Triple-Negative Breast Cancer.

|Sep 14, 2022
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction.

Kenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson

|Aug 26, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.

Javier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia

|Aug 03, 2022
Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells.

Sophia Ceder, Sofi E Eriksson, Ying Yu Liang

|Mar 25, 2022
Sideroflexin 4 is a complex I assembly factor that interacts with the MCIA complex and is required for the assembly of the ND2 module.

Thomas D Jackson, Jordan J Crameri, Linden Muellner-Wong

|Jul 28, 2021
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status.

Kenji M Fujihara, Mariana Corrales Benitez, Carlos S Cabalag

Pageof 2

Frequent Collaborators

6 joint publications

Nicholas J Clemons

3 joint publications

Klas G Wiman

3 joint publications

Kaylene J Simpson

3 joint publications

Sue Haupt